Skip to main content

Advertisement

Log in

Nigrostriatal involvement in ataxia with oculomotor apraxia type 1

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Ataxia with oculomotor apraxia type 1 (AOA1) is a rare autosomal recessive neurodegenerative disease, recently associated with mutations in the aprataxin gene. Main features are early onset cerebellar ataxia, oculomotor apraxia and peripheral neuropathy. The presence of choreoathetosis or dystonia in some patients suggests basal ganglia involvement, but these structures appear preserved in a single case in which neuropathological examination was performed. To evaluate in vivo the nigrostriatal function we studied dopamine transporter (DAT) density with [123I] 2beta-carbometoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FPCIT)-SPECT in four AOA1 patients and eight healthy volunteers. All patients showed ataxia and neuropathy; only one had chorea and none had dystonia. Comparing with controls, AOA1 patients showed a slight reduction of the average striatal DAT density, which was bilateral and uniform in caudate and putamen. Nigrostriatal impairment occurred even in the absence of extrapyramidal features. Our data suggest subclinical involvement of basal ganglia in AOA1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barbot C, Coutinho P, Chorao R, et al. (2001) Recessive ataxia with ocular apraxia: review of 22 Portuguese patients. Arch Neurol 58:201–205

    Article  PubMed  CAS  Google Scholar 

  2. Cardoso F, Seppi K, Mair KJ, et al. (2006) Seminar on choreas. Lancet Neurol 5:589–602

    Article  PubMed  Google Scholar 

  3. Criscuolo C, Mancini P, Menchise V, et al. (2005) Very late onset in ataxia oculomotor apraxia type I. Ann Neurol 57:777

    Article  PubMed  CAS  Google Scholar 

  4. Criscuolo C, Mancini P, Sacca F, et al. (2004) Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype. Neurology 14(63):2173–2175

    Google Scholar 

  5. Date H, Onodera O, Tanaka,H, et al. (2001) Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nature Genet 29: 184–188

    Article  PubMed  CAS  Google Scholar 

  6. Ginovart N, Lundin A, Farde L, et al. (1997) PET study of the pre- and postsynaptic dopaminergic markers for the neurodegenerative process in Huntington’s disease. Brain 120:503–514

    Article  PubMed  Google Scholar 

  7. Gunther P, Storch A, Schwarz J, et al. (2004) Basal ganglia involvement of a patient with SCA 17 – a new form of autosomal dominant spinocerebellar ataxia. J Neurol 251:896–897

    Article  PubMed  CAS  Google Scholar 

  8. Le Ber I, Moreira MC, Rivaud-Pechoux S, et al. (2003) Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 126:2761–2772

    Article  PubMed  Google Scholar 

  9. Moreira MC, Barbot C, Tachi N, et al. (2001) The gene mutated in ataxiaocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Gene 291:189–193

    Article  Google Scholar 

  10. Sekijima Y, Hashimoto T, Onodera O, et al. (2003) Severe generalized dystonia as a presentation of a patient with aprataxin gene mutation. Mov Disord 18:1198–1200

    Article  PubMed  Google Scholar 

  11. Sekijima Y, Ohara S,Nakagawa S, et al. (1998) Hereditary motor and sensory neuropathy associated with cerebellar atrophy (HMSNCA): clinical and neuropathological features of a Japanese family. J Neurol Sci 158:30–37

    Article  PubMed  CAS  Google Scholar 

  12. Shimazaki H, Takiyama Y, Sakoe K, et al. (2002) Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations. Neurology 27(59):590–595

    Google Scholar 

  13. Tranchant C, Fleury M,Moreira MC, et al. (2003) Phenotypic variability of aprataxin gene mutations. Neurology 11; 60:868–870

    Article  PubMed  CAS  Google Scholar 

  14. Trouillas P, Takayanagi T, Hallet M, et al. (1997) International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 145:205–211

    Article  PubMed  CAS  Google Scholar 

  15. Salvatore E, Varrone A, Sansone V, et al. (2006) Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17. Mov Disord 21:872–875

    Article  PubMed  Google Scholar 

  16. Varrone A, Salvatore E, De Michele G, et al. (2004) Reduced striatal [123I]FPCIT binding in SCA2 patients without parkinsonism. Ann Neurol 55:426–430

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. Salvatore MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salvatore, E., Varrone, A., Criscuolo, C. et al. Nigrostriatal involvement in ataxia with oculomotor apraxia type 1. J Neurol 255, 45–48 (2008). https://doi.org/10.1007/s00415-007-0657-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-0657-x

Key words

Navigation